Franck M.
- Country
- France
- Department
- Service des Maladies du Sang
Research Overview
- Phase 1 Study of JNJ-80948543, a T-cell Redirecting Antibody, in Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia Patients
- Evaluation of Venetoclax Combined With Polatuzumab Vedotin, Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone in Untreated BCL-2 IHC-Positive DLBCL Patients
- TRANSCRIPT: An open label, controlled, randomized multicentric international study evaluating the benefit of autologous stem cell transplantation after complete response in frontline setting patients with T cell-lymphoma
Data & Insights
Has run more than one trial at 282 of 457 partner sites.
Specializations
Lymphoma Expertise
Specializes in treating various forms of B-cell lymphomas, with particular focus on diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma. Conducts innovative research in both newly diagnosed and relapsed/refractory cases.
- Aggressive B-cell lymphomas
- Mantle cell lymphoma
- Marginal zone lymphoma
Treatment Approaches
Investigates novel therapeutic strategies including CAR T-cell therapy, bispecific antibodies, and targeted combinations. Focuses on developing personalized treatment protocols for various lymphoma subtypes.
- Immunotherapy applications
- Combination therapies
- Novel drug development
Clinical Focus
Specializes in treating relapsed/refractory disease and developing new therapeutic strategies for patients who have exhausted standard treatment options. Experienced in managing both classical Hodgkin lymphoma and various non-Hodgkin lymphoma subtypes.
- Treatment resistance
- Early-phase clinical trials
- Patient-specific approaches
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.